<?xml version="1.0" encoding="UTF-8"?>
<p>Cisplatin, which is a cornerstone of chemotherapy for the treatment of multiple cancers, is a highly emetogenic chemotherapy drug.
 <sup>[
  <xref rid="R6" ref-type="bibr">6</xref>]
 </sup> Over 90% cancer patients will vomit within the first 24â€Šhours after the administration of cisplatin-based chemotherapy unless antiemetic drugs are used.
 <sup>[
  <xref rid="R7" ref-type="bibr">7</xref>]
 </sup> Even with the guideline-recommended antiemetic drugs, cisplatin-induced vomiting is controlled in only 60% of patients; therefore, considerable numbers of patients still experience nausea.
 <sup>[
  <xref rid="R8" ref-type="bibr">8</xref>]
 </sup>
</p>
